Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
In high-risk myeloma, look beyond VRD for induction
There’s more to induction therapy for transplant-eligible multiple myeloma patients than the go-to combination of bortezomib, lenalidomide, and...
News
Why CLL may go chemo free
NEW YORK – The approach to treating chronic lymphocytic leukemia is evolving, and while chemoimmunotherapy remains a reasonable initial option in...
News
Review offers reassurance on prenatal Tdap vaccination safety
Are prenatal Tdap vaccinations safe during the second and third trimester? New findings suggest that they probably are.
News
Optimal adjuvant endocrine therapy use in breast cancer remains elusive
Appropriate use of adjuvant endocrine therapy for breast cancer has increased over the last decade, but optimal use has not been achieved.
News
Cabozantinib shows promise for carcinoid tumors, pNET
Cabozantinib treatment was associated with objective tumor responses and encouraging progression-free survival in advanced carcinoid and...
News
Nivolumab shows promise for pretreated advanced HCC
SAN FRANCISCO – Nivolumab was associated with durable responses in heavily pretreated patients with advanced hepatocellular carcinoma in the dose-...
News
Adjuvant GEMOX disappoints for localized biliary tract cancer
SAN FRANCISCO – Postsurgery adjuvant treatment with gemcitabine and oxaliplatin (GEMOX) was feasible, but failed to significantly improve relapse-...
News
Bursectomy provides no benefit over omentectomy for gastric cancers
Bursectomy was not found to be superior to omentectomy for improving survival in patients with subserosal/serosal gastric cancer in a Japanese...
News
Everolimus fails in pretreated gastric cancer
Adding everolimus to paclitaxel failed to significantly improve outcomes in pretreated patients with gastric or esophagogastric junction...
Article
Ramucirumab benefits gastric cancer patients across age groups
Patients with metastatic gastric or gastroesophageal junction adenocarcinoma benefit from treatment with ramucirumab regardless of their age,...
News
Ohio progestogen program reduced early preterm births
A statewide progestogen promotion program that aimed to reduce premature births in Ohio by 10% is exceeding its goals, thanks to a joint effort of...
Article
Nivolumab safe, effective for salvage in advanced gastric cancer
The human monoclonal IgG4 antibody nivolumab was safe and effective as a salvage treatment for patients in a randomized phase III trial who failed...
Article
PET-directed induction therapy improves esophageal cancer outcomes
The use of positron emission tomography to assess esophageal tumor response to induction chemotherapy and to guide a regimen change in those who...
Article
Circulating microRNAs may predict breast cancer treatment response
SAN ANTONIO – Circulating microRNAs may predict treatment response in HER2-positive breast cancer patients treated with neoadjuvant therapy,...
Article
Surgical discharge data highlight stewardship need at transition
Most antibiotic prescriptions written at the time of patient discharge at an academic hospital were inappropriate – despite the existence of a...